Drug Information

Drug General Information
Drug ID
D0YV4F
Former ID
DCL000581
Drug Name
Ocrelizumab
Synonyms
Ocrelizumab (USAN); Ocrelizumab (genetical recombination); Ocrelizumab (genetical recombination) (JAN)
Drug Type
Antibody
Indication Relapsing or primary progressive forms of multiple sclerosis [ICD10:G35] Approved [889446]
Company
Genentech
CAS Number
CAS 637334-45-3
PubChem Substance ID
47206937
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info [536651], [551607]
KEGG Pathway Hematopoietic cell lineage
References
Ref 889446Drugs@FDA (Edaravone)
Ref 536651Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
Ref 551607Clinical pipeline report, company report or official report of Roche (2009).